Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Receives $6.3m R&D Tax Refund

Jan 24, 2025 at 3:20 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment